Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Horuk

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Frontiers in Bioscience (Elite Edition)|June 2, 2009
Drug discovery targeting the chemokine system--where are we?Richard Horuk, Amanda E I Proudfoot
Expert Opinion on Therapeutic Targets|January 24, 2003
The biology and physiology of somatostatin receptorsHong-Tao Lu, Hugh Salamon, Richard Horuk
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
Chemokines in transplant rejectionChristopher A Haskell, Sofia Ribeiro, Richard Horuk
Methods in Enzymology|May 19, 2009
Modeling small molecule-compound binding to G-protein-coupled receptorsNagarajan Vaidehi, James E Pease, Richard Horuk
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 20, 2007
Treatment with BX471, a CC chemokine receptor 1 antagonist, attenuates systemic inflammatory response during sepsisMin He, Richard Horuk, Shabbir M Moochhala, et al.
Protein Expression and Purification|March 12, 2009
Expression, purification and in vitro functional reconstitution of the chemokine receptor CCR1Samantha J Allen, Sofia Ribeiro, Richard Horuk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2008
Chemokine receptor CCR1 regulates inflammatory cell infiltration after renal ischemia-reperfusion injuryKengo Furuichi, Ji-Liang Gao, Richard Horuk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2003
Structure function differences in nonpeptide CCR1 antagonists for human and mouse CCR1James Onuffer, Margaret A McCarrick, Laura Dunning, et al.
Journal of Molecular and Cellular Cardiology|May 16, 2006
A CCR1 antagonist prevents the development of experimental autoimmune myocarditis in association with T cell inactivationHideki Futamatsu, Jun-ichi Suzuki, Noritaka Koga, et al.
Annals of Neurology|November 5, 2003
CCR1 is an early and specific marker of Alzheimer's diseaseMeredith Halks-Miller, Miriam L Schroeder, Vahram Haroutunian, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Frontiers in Bioscience (Elite Edition)|June 2, 2009
Drug discovery targeting the chemokine system--where are we?Richard Horuk, Amanda E I Proudfoot
Expert Opinion on Therapeutic Targets|January 24, 2003
The biology and physiology of somatostatin receptorsHong-Tao Lu, Hugh Salamon, Richard Horuk
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
Chemokines in transplant rejectionChristopher A Haskell, Sofia Ribeiro, Richard Horuk
Methods in Enzymology|May 19, 2009
Modeling small molecule-compound binding to G-protein-coupled receptorsNagarajan Vaidehi, James E Pease, Richard Horuk
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 20, 2007
Treatment with BX471, a CC chemokine receptor 1 antagonist, attenuates systemic inflammatory response during sepsisMin He, Richard Horuk, Shabbir M Moochhala, et al.
Protein Expression and Purification|March 12, 2009
Expression, purification and in vitro functional reconstitution of the chemokine receptor CCR1Samantha J Allen, Sofia Ribeiro, Richard Horuk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 4, 2008
Chemokine receptor CCR1 regulates inflammatory cell infiltration after renal ischemia-reperfusion injuryKengo Furuichi, Ji-Liang Gao, Richard Horuk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2003
Structure function differences in nonpeptide CCR1 antagonists for human and mouse CCR1James Onuffer, Margaret A McCarrick, Laura Dunning, et al.
Journal of Molecular and Cellular Cardiology|May 16, 2006
A CCR1 antagonist prevents the development of experimental autoimmune myocarditis in association with T cell inactivationHideki Futamatsu, Jun-ichi Suzuki, Noritaka Koga, et al.
Annals of Neurology|November 5, 2003
CCR1 is an early and specific marker of Alzheimer's diseaseMeredith Halks-Miller, Miriam L Schroeder, Vahram Haroutunian, et al.
Pageof 6